AI Generated Image
Over 11,000 bottles of blood pressure medication recalled nationwide
Fox Business • • business
Key Points:
- The FDA announced a nationwide recall of 11,460 bottles of chlorthalidone tablets, USP, 25 mg, due to failed dissolution specifications affecting drug quality.
- The medication, used to treat high blood pressure and reduce swelling, was manufactured by Inventia Healthcare Limited in India and distributed in the U.S. by Rising Pharma Holdings.
- The recall, initiated voluntarily by Inventia Healthcare on June 5, includes bottles of 100 and 1000 tablets with specific batch codes RISA24001 and RISB24002, expiring in April 2027.
- Dissolution testing failure indicates the drug may not release its active ingredient properly, potentially impacting treatment effectiveness for patients.
- Both companies have been contacted for comment, and the FDA continues to monitor the recall process to ensure public safety.
